antibody-RNA conjugate

Sanofi licenses a preclinical genetic disease drug from an unknown biotech spun out of the NIH
Endpoints
Tue, 10/4/22 - 10:47 am
Sanofi
antibody-RNA conjugate
miRecule
FSHD